Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Shapiro

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|April 4, 2019
Cancer Survivorship. ReplyCharles L Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Aromatase inhibitors and bone loss: risks in perspectiveCharles L Shapiro
JAMA Oncology|September 9, 2016
Highlights of Recent Findings on Quality-of-Life Management for Patients With Cancer and Their SurvivorsCharles L Shapiro
Breast Cancer Research and Treatment|August 11, 2010
Estrogen deficiency and bone loss in women with breast cancerCharles L Shapiro
Clinical Advances in Hematology & Oncology : H&O|June 13, 2009
Bisphosphonates as adjuvant therapyCharles L Shapiro
Annals of Translational Medicine|September 21, 2020
Caring about bone-modifying agents (BMAs) in women with early-stage breast cancerCharles L Shapiro
Cancers|October 29, 2020
Osteoporosis: A Long-Term and Late-Effect of Breast Cancer TreatmentsCharles L Shapiro
The New England Journal of Medicine|December 22, 2018
Cancer SurvivorshipCharles L Shapiro
Clinical Breast Cancer|May 28, 2021
Bone-modifying Agents (BMAs) in Breast CancerCharles L Shapiro
NPJ Breast Cancer|August 21, 2019
De-escalation yes, but not at the expense of efficacy: in defense of better treatmentCharles L Shapiro
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|April 4, 2019
Cancer Survivorship. ReplyCharles L Shapiro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Aromatase inhibitors and bone loss: risks in perspectiveCharles L Shapiro
JAMA Oncology|September 9, 2016
Highlights of Recent Findings on Quality-of-Life Management for Patients With Cancer and Their SurvivorsCharles L Shapiro
Breast Cancer Research and Treatment|August 11, 2010
Estrogen deficiency and bone loss in women with breast cancerCharles L Shapiro
Clinical Advances in Hematology & Oncology : H&O|June 13, 2009
Bisphosphonates as adjuvant therapyCharles L Shapiro
Annals of Translational Medicine|September 21, 2020
Caring about bone-modifying agents (BMAs) in women with early-stage breast cancerCharles L Shapiro
Cancers|October 29, 2020
Osteoporosis: A Long-Term and Late-Effect of Breast Cancer TreatmentsCharles L Shapiro
The New England Journal of Medicine|December 22, 2018
Cancer SurvivorshipCharles L Shapiro
Clinical Breast Cancer|May 28, 2021
Bone-modifying Agents (BMAs) in Breast CancerCharles L Shapiro
NPJ Breast Cancer|August 21, 2019
De-escalation yes, but not at the expense of efficacy: in defense of better treatmentCharles L Shapiro
Pageof 16